Clinical Trials Directory

Trials / Completed

CompletedNCT01442727

Selenium in the Treatment of Arsenic Toxicity and Cancers

Selenite in the Detoxification of Arsenic and the Prevention of Arsenical Melanosis and Cancers Amongst Bangladeshi Arsenicosis Patients: A 48-week, Randomized, Double-blinded, Placebo-controlled Phase III Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
819 (actual)
Sponsor
Texas Tech University · Academic / Other
Sex
All
Age
12 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Context: Approximately 100 million people throughout the world consume water contaminated with arsenic at levels above carcinogenic thresholds, including 40 million in Bangladesh alone, with up to one-fourth of deaths attributed to arsenic exposure in the worst-affected regions. There are no proven therapies for treating chronic arsenic toxicity or for preventing arsenical cancers. Selenium has been known to counter arsenic toxicity in a variety of animal models. The investigators have recently shown in animals and humans that this effect is mediated by the formation of \[(GS)2AsSe\]- , the seleno-bis(S-glutathionyl) arsinium ion, which is then rapidly excreted via the hepatobiliary system. Concurrently, two Phase II studies in China and Bangladesh have suggested clinical benefit to selenium supplementation in arsenicosis patients. Objective: To assess whether daily selenium supplementation counters arsenic toxicity in patients exposed to drinking water arsenic. If proven effective, selenium supplementation might be safely and cost-effectively implemented in the worst-affected localities.

Conditions

Interventions

TypeNameDescription
DRUGsodium selenite200 micrograms (µg) of selenium in the form of sodium selenite; capsule form consumed once daily with breakfast.
DRUGplacebodicalcium phosphate capsule matching the selenium capsule in appearance; consumed once daily with breakfast

Timeline

Start date
2006-12-01
Primary completion
2009-04-01
Completion
2009-04-01
First posted
2011-09-28
Last updated
2011-10-07

Locations

1 site across 1 country: Bangladesh

Source: ClinicalTrials.gov record NCT01442727. Inclusion in this directory is not an endorsement.